Catalog |
name |
Description |
price |
R-M1-8677 |
Blank Lipid nanoparticles-CY7/ GIn(100nm) |
Blank Lipid nanoparticles-CY7/ GIn(100nm)/Blank liposome nanoparticles-CY7/ GIn(100nm) can be used for drug loading, drug delivery and targeted cell research. |
price> |
R-M1-8692 |
Liposome-encapsulated Prussian Blue Nanoparticles |
Liposome-encapsulated Prussian Blue nanoparticles offer several advantages. Firstly, liposome encapsulation enhances the stability and biodegradability of Prussian Blue nanoparticles, extending their circulation time within the body. Secondly, liposomes increase the drug loading capacity of nanoparticles, improving their efficiency as drug carriers. Additionally, liposomes possess good targeting abilities, allowing for targeted delivery to specific cells or tissues through modifications in liposome structure or surface modifications. |
price> |
R-C-6575 |
HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide/MPL (49/45/4/1/1, mol/mol) Liposomes |
Immunogenic PEGylated liposomes containing free maleimide functional group for maleimide-thiol conjugation,plus TLR4 agonist MPL for adjuvant activity.The liposomes are co-formulated with 1 mol% DSPE-mPEG2000-maleimide,and supplied in a pH-optimized buffer for direct conjugation of the thiol-containing molecule of choice. |
price> |
R-C-6576 |
HSPC/Chol/DSPE-mPEG2000/MPL (56.2/38.5/4.3/1, mol/mol) Liposomes |
The product is a kind of neutral PEGylated liposome.Neutral liposomes are generally non-toxic and relatively stable in serum.PEG has been proven to improve the stability of liposomes and increase the circulation time of liposomes in the blood.Therefore,PEGylated liposomes have enhanced tumor permeability and retention effect (EPR) and improved tumor uptake. |
price> |
R-C-6577 |
HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3, mol/mol) Liposomes |
HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3,mol/mol) liposomes,30 mM,extruded and supplied sterile-filtered in glass vial.PEGylated to improve stability,prolong circulation time and reduce reticuloendothelial system clearance. |
price> |
R-C-6578 |
DMPC/Chol/DSPE-mPEG2000 (50/45/5, mol/mol) Liposomes |
Liposomes composed of a mixture of DMPC(1,2-dimyristoyl-sn-glycero-3-phosphocholine),cholesterol (Chol),and DSPE-mPEG2000(1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]) with mole ratios of 50/45/5 respectively are a type of nanocarrier used in drug delivery and other biomedical applications. |
price> |
R-C-6579 |
HSPC/Chol/DSPE-mPEG2000 (50/45/5, mol/mol) Liposomes |
Liposomes composed of HSPC(hydrogenated soy phosphatidylcholine),cholesterol(Chol),and mPEG-DSPE(1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)])are commonly used in drug delivery systems.These liposomes leverage the properties of their constituents to provide stability,biocompatibility,and prolonged circulation times. |
price> |
R-C-6580 |
DSPC/Chol/DSPE-mPEG2000 (50/45/5,mol/mol) Liposomes |
The DSPC/Chol/DSPE-mPEG2000 liposomes represent a robust system designed for enhancing the delivery and efficacy of therapeutic compounds.Their balanced composition allows them to be versatile in various applications,owing to the stability provided by DSPC and cholesterol,combined with the stealth properties introduced by DSPE-mPEG2000. |
price> |
R-C-6581 |
HSPC/DSPE-mPEG2000 (95/5, mol/mol) Liposomes |
The formulation HSPC/DSPE-mPEG2000 (95/5, mol/mol) primarily of HSPC (Hydrogenated Soy Phosphatidylcholine)and a small percentage of DSPE-mPEG2000 (1,2-Distearoyl-sn-glycero-3-phosphoethanolamine conjugated with methoxy polyethylene glycol 2000),Can load medication.Our product is only used for scientific research and not for human clinical trials. |
price> |
R-C-6582 |
DSPC/DSPE-mPEG2000 (95/5, mol/mol) Liposomes |
PEGylated liposomes,the main component of which is phosphatidylcholine (PC),
It is the most abundant phospholipid in eukaryotic cell membranes and can form lipid bilayers. |
price> |